Eaton Vance Management Regeneron Pharmaceuticals, Inc. Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Eaton Vance Management holds 60,662 shares of REGN stock, worth $46.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

60,662

Previous 60,396 0.44%

Holding current value

$46.9 Million

Previous $35.7 Million 17.05%

% of portfolio

0.06%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $152,676 - $192,669	266 Added 0.44%	60,662 $41.8 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $1.72 Million - $2.32 Million	3,143 Added 5.49%	60,396 $35.7 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $15.4 Million - $18.1 Million	25,907 Added 82.65%	57,253 $40 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $52,174 - $64,413	96 Added 0.31%	31,346 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.11 Million - $1.32 Million	1,939 Added 6.62%	31,250 $18.5 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $207,086 - $244,640	438 Added 1.52%	29,311 $16.4 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $22,783 - $27,958	51 Added 0.18%	28,873 $13.7 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $497,910 - $632,907	-1,041 Reduced 3.49%	28,822 $13.9 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $999,616 - $1.21 Million	1,835 Added 6.55%	29,863 $16.7 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $989,599 - $1.29 Million	2,006 Added 7.71%	28,028 $17.5 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $17,817 - $26,204	53 Added 0.2%	26,022 $12.7 Million
Q4 2019 Feb 11, 2020	BUY	$274.13 - $376.51 $1.1 Million - $1.51 Million	4,003 Added 18.22%	25,969 $9.75 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $3,281 - $3,820	12 Added 0.05%	21,966 $6.09 Million
Q2 2019 Aug 16, 2019	SELL	$299.6 - $414.82 $421,537 - $583,651	-1,407 Reduced 6.02%	21,954 $6.87 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $9,674 - $11,428	-26 Reduced 0.11%	23,361 $9.59 Million
Q4 2018 Feb 07, 2019	SELL	$335.82 - $403.04 $58,432 - $70,128	-174 Reduced 0.74%	23,387 $8.74 Million
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $10.1 Million - $12.3 Million	-35,529 Reduced 60.13%	23,561 $8.13 Million
Q1 2018 May 07, 2018	SELL	$315.82 - $393.78 $1.42 Million - $1.78 Million	-4,512 Reduced 7.09%	59,090 $20.3 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $1.91 Million - $2.51 Million	5,332 Added 9.15%	63,602 $23.9 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $25.1 Million - $29.4 Million	58,270	58,270 $26.1 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $82.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Regeneron Pharmaceuticals, Inc. Transaction History